Nomura Holdings Inc Repligen Corp Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $2.11 Million - $3.22 Million	17,601 New	17,601 $2.22 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $3.44 Million - $4.23 Million	-13,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $214,247 - $356,631	1,100 Added 8.59%	13,900 $3.91 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $1.26 Million - $1.67 Million	-7,569 Reduced 37.16%	12,800 $2.57 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $2.38 Million - $2.98 Million	13,168 Added 182.86%	20,369 $3.97 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $1.07 Million - $1.49 Million	7,201 New	7,201 $1.38 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.